Cargando…

Computational Prediction of Drug Solubility in Lipid Based Formulation Excipients

PURPOSE: To investigate if drug solubility in pharmaceutical excipients used in lipid based formulations (LBFs) can be predicted from physicochemical properties. METHODS: Solubility was measured for 30 structurally diverse drug molecules in soybean oil (SBO, long-chain triglyceride; TG(LC)), Captex3...

Descripción completa

Detalles Bibliográficos
Autores principales: Persson, Linda C., Porter, Christopher J. H., Charman, William N., Bergström, Christel A. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841656/
https://www.ncbi.nlm.nih.gov/pubmed/23771564
http://dx.doi.org/10.1007/s11095-013-1083-7
_version_ 1782292821707849728
author Persson, Linda C.
Porter, Christopher J. H.
Charman, William N.
Bergström, Christel A. S.
author_facet Persson, Linda C.
Porter, Christopher J. H.
Charman, William N.
Bergström, Christel A. S.
author_sort Persson, Linda C.
collection PubMed
description PURPOSE: To investigate if drug solubility in pharmaceutical excipients used in lipid based formulations (LBFs) can be predicted from physicochemical properties. METHODS: Solubility was measured for 30 structurally diverse drug molecules in soybean oil (SBO, long-chain triglyceride; TG(LC)), Captex355 (medium-chain triglyceride; TG(MC)), polysorbate 80 (PS80; surfactant) and PEG400 co-solvent and used as responses during PLS model development. Melting point and calculated molecular descriptors were used as variables and the PLS models were validated with test sets and permutation tests. RESULTS: Solvation capacity of SBO and Captex355 was equal on a mol per mol scale (R (2) = 0.98). A strong correlation was also found between PS80 and PEG400 (R (2) = 0.85), identifying the significant contribution of the ethoxylation for the solvation capacity of PS80. In silico models based on calculated descriptors were successfully developed for drug solubility in SBO (R (2) = 0.81, Q (2) = 0.76) and Captex355 (R (2) = 0.84, Q (2) = 0.80). However, solubility in PS80 and PEG400 were not possible to quantitatively predict from molecular structure. CONCLUSION: Solubility measured in one excipient can be used to predict solubility in another, herein exemplified with TG(MC) versus TG(LC), and PS80 versus PEG400. We also show, for the first time, that solubility in TG(MC) and TG(LC) can be predicted from rapidly calculated molecular descriptors.
format Online
Article
Text
id pubmed-3841656
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-38416562013-12-02 Computational Prediction of Drug Solubility in Lipid Based Formulation Excipients Persson, Linda C. Porter, Christopher J. H. Charman, William N. Bergström, Christel A. S. Pharm Res Research Paper PURPOSE: To investigate if drug solubility in pharmaceutical excipients used in lipid based formulations (LBFs) can be predicted from physicochemical properties. METHODS: Solubility was measured for 30 structurally diverse drug molecules in soybean oil (SBO, long-chain triglyceride; TG(LC)), Captex355 (medium-chain triglyceride; TG(MC)), polysorbate 80 (PS80; surfactant) and PEG400 co-solvent and used as responses during PLS model development. Melting point and calculated molecular descriptors were used as variables and the PLS models were validated with test sets and permutation tests. RESULTS: Solvation capacity of SBO and Captex355 was equal on a mol per mol scale (R (2) = 0.98). A strong correlation was also found between PS80 and PEG400 (R (2) = 0.85), identifying the significant contribution of the ethoxylation for the solvation capacity of PS80. In silico models based on calculated descriptors were successfully developed for drug solubility in SBO (R (2) = 0.81, Q (2) = 0.76) and Captex355 (R (2) = 0.84, Q (2) = 0.80). However, solubility in PS80 and PEG400 were not possible to quantitatively predict from molecular structure. CONCLUSION: Solubility measured in one excipient can be used to predict solubility in another, herein exemplified with TG(MC) versus TG(LC), and PS80 versus PEG400. We also show, for the first time, that solubility in TG(MC) and TG(LC) can be predicted from rapidly calculated molecular descriptors. Springer US 2013-06-15 2013 /pmc/articles/PMC3841656/ /pubmed/23771564 http://dx.doi.org/10.1007/s11095-013-1083-7 Text en © The Author(s) 2013 https://creativecommons.org/licenses/by-nc/2.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Research Paper
Persson, Linda C.
Porter, Christopher J. H.
Charman, William N.
Bergström, Christel A. S.
Computational Prediction of Drug Solubility in Lipid Based Formulation Excipients
title Computational Prediction of Drug Solubility in Lipid Based Formulation Excipients
title_full Computational Prediction of Drug Solubility in Lipid Based Formulation Excipients
title_fullStr Computational Prediction of Drug Solubility in Lipid Based Formulation Excipients
title_full_unstemmed Computational Prediction of Drug Solubility in Lipid Based Formulation Excipients
title_short Computational Prediction of Drug Solubility in Lipid Based Formulation Excipients
title_sort computational prediction of drug solubility in lipid based formulation excipients
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841656/
https://www.ncbi.nlm.nih.gov/pubmed/23771564
http://dx.doi.org/10.1007/s11095-013-1083-7
work_keys_str_mv AT perssonlindac computationalpredictionofdrugsolubilityinlipidbasedformulationexcipients
AT porterchristopherjh computationalpredictionofdrugsolubilityinlipidbasedformulationexcipients
AT charmanwilliamn computationalpredictionofdrugsolubilityinlipidbasedformulationexcipients
AT bergstromchristelas computationalpredictionofdrugsolubilityinlipidbasedformulationexcipients